Register to leave comments

  • News bot April 7, 2026, 11:36 a.m.

    📋 WW INTERNATIONAL, INC. (WW) - Clinical Trial Update

    Filing Date: 2026-04-07

    Accepted: 2026-04-07 07:35:06

    Event Type: Clinical Trial Update

    Event Details:

    WW INTERNATIONAL, INC. (WW) Announces Clinical Trial Update WW INTERNATIONAL, INC. (WW) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: leader
    • Diseases/Conditions: science-backed weight management
    • Collaboration: Weight Watchers

    🔬 Clinical Development Pipeline (WW INTERNATIONAL, INC.):

    Product Type Development Stage Therapeutic Area Source
    Phentermine Hydrochloride 8 MG DRUG Phase PHASE4 Obesity ClinicalTrials.gov
    Online Lifestyle Behavioral Therapy BEHAVIORAL Phase PHASE4 Obesity ClinicalTrials.gov
    Safety Planning Intervention BEHAVIORAL Approved HIV - Human Immunodeficiency Virus ClinicalTrials.gov
    IDEAS for Hope BEHAVIORAL Approved HIV - Human Immunodeficiency Virus ClinicalTrials.gov
    Usual Care BEHAVIORAL Approved Diabetes Mellitus ClinicalTrials.gov
    WW Intervention BEHAVIORAL Approved Diabetes Mellitus ClinicalTrials.gov
    Oral nitrofurantoin monohydrate/macrocrystals DRUG Phase PHASE3 Preterm Birth ClinicalTrials.gov
    self-guided mHealth app + 'real-time' feedback BEHAVIORAL Approved Alcohol Abuse ClinicalTrials.gov
    self-guided mHealth app only BEHAVIORAL Approved Alcohol Abuse ClinicalTrials.gov
    Commercial weight management program BEHAVIORAL Approved Obesity and Overweight ClinicalTrials.gov
    Bupropion-Naltrexone-Metformin DRUG Phase PHASE4 Obesity ClinicalTrials.gov
    Bupropion-Naltrexone DRUG Phase PHASE4 Obesity ClinicalTrials.gov
    WW Clinic BEHAVIORAL Phase PHASE4 Obesity ClinicalTrials.gov
    Relapse Prevention (RP) BEHAVIORAL Approved Alcohol Use Disorder ClinicalTrials.gov
    Behavioral Activation (BA) BEHAVIORAL Approved Alcohol Use Disorder ClinicalTrials.gov
    Transition Health and Resilience through Valued Experiences (THRiVE) Program BEHAVIORAL Approved Military Transition ClinicalTrials.gov
    One-time education OTHER Approved Cervical Cancer ClinicalTrials.gov
    ARROW strategies OTHER Approved Cervical Cancer ClinicalTrials.gov
    Video-counseling+app BEHAVIORAL Approved HIV/AIDS ClinicalTrials.gov
    Standard of Care OTHER Approved HIV/AIDS ClinicalTrials.gov
    Quality-of-Life Assessment OTHER Phase EARLY_PHASE1 Osteosarcoma ClinicalTrials.gov
    Glucarpidase DRUG Phase EARLY_PHASE1 Osteosarcoma ClinicalTrials.gov
    WW BEHAVIORAL Approved Obesity ClinicalTrials.gov
    Inhibitory control training (RESIST) BEHAVIORAL Approved Obesity ClinicalTrials.gov
    Home food environment and grocery delivery (AVOID) BEHAVIORAL Approved Obesity ClinicalTrials.gov
    Safe Dates for Young Parents (SDYP) BEHAVIORAL Approved Gender-based Violence ClinicalTrials.gov
    Clonidine Gel 0.1% DRUG Phase PHASE2 Painful Diabetic Neuropathy ClinicalTrials.gov
    BEMA Buprenorphine NX DRUG Phase PHASE3 Opioid Dependence ClinicalTrials.gov
    BEMA Buprenorphine NX films DRUG Phase PHASE2 Opioid Dependence ClinicalTrials.gov
    Placebo capsule DRUG Phase PHASE2 Pain ClinicalTrials.gov
    Morphine sulfate DRUG Phase PHASE2 Pain ClinicalTrials.gov
    Placebo film DRUG Phase PHASE2 Pain ClinicalTrials.gov
    Buprenorphine and naloxone DRUG Phase PHASE3 Opioid Dependence ClinicalTrials.gov
    Clonidine Hydrochloride Gel Comparator DRUG Phase PHASE2 Painful Diabetic Neuropathy ClinicalTrials.gov
    Clonidine Hydrochloride Topical Gel, 0.1% DRUG Phase PHASE2 Painful Diabetic Neuropathy ClinicalTrials.gov
    BEMA Buprenorphine DRUG Phase PHASE3 Pain ClinicalTrials.gov
    Oxycodone DRUG Phase PHASE2 Pain ClinicalTrials.gov
    Buprenorphine DRUG Phase PHASE3 Low Back Pain ClinicalTrials.gov
    BEMA Fentanyl DRUG Phase PHASE3 Pain ClinicalTrials.gov
    EN3409 DRUG Phase PHASE3 Low Back Pain ClinicalTrials.gov
    BEMA™ DRUG Phase PHASE3 Pain ClinicalTrials.gov
    Oxycodone 60 mg DRUG Phase PHASE1 Respiratory Depression ClinicalTrials.gov
    Oxycodone 30 mg DRUG Phase PHASE1 Respiratory Depression ClinicalTrials.gov
    Belbuca 900 µg DRUG Phase PHASE1 Respiratory Depression ClinicalTrials.gov
    Belbuca 600 µg DRUG Phase PHASE1 Respiratory Depression ClinicalTrials.gov
    Belbuca 300 µg DRUG Phase PHASE1 Respiratory Depression ClinicalTrials.gov
    DFN-15 Placebo OTHER Phase PHASE3 Migraine Headache ClinicalTrials.gov
    DFN-15 Active DRUG Phase PHASE3 Migraine Headache ClinicalTrials.gov
    PROMIS - sleep BEHAVIORAL Phase PHASE4 Back Pain Lower Back Chronic ClinicalTrials.gov
    patient global impression of function BEHAVIORAL Phase PHASE4 Back Pain Lower Back Chronic ClinicalTrials.gov
    numerical rating scale pain score OTHER Phase PHASE4 Back Pain Lower Back Chronic ClinicalTrials.gov
    sit to stand test OTHER Phase PHASE4 Back Pain Lower Back Chronic ClinicalTrials.gov
    PROMIS 29 BEHAVIORAL Phase PHASE4 Back Pain Lower Back Chronic ClinicalTrials.gov
    actigraph DEVICE Phase PHASE4 Back Pain Lower Back Chronic ClinicalTrials.gov
    Urine Drug Screening OTHER Phase PHASE4 Back Pain Lower Back Chronic ClinicalTrials.gov
    Buprenorphine Buccal Film [Belbuca] DRUG Phase PHASE4 Back Pain Lower Back Chronic ClinicalTrials.gov
    Naloxegol DRUG Preclinical Opioid-induced Constipation ClinicalTrials.gov
    Lubiprostone DRUG Preclinical Opioid-induced Constipation ClinicalTrials.gov
    Naldemedine DRUG Preclinical Opioid-induced Constipation ClinicalTrials.gov
    Placebo OTHER Phase PHASE3 Preterm Birth ClinicalTrials.gov
    Typbar-TCV DRUG Phase PHASE2 Trivalent Salmonella Conjugate Vaccine (TSCV) ClinicalTrials.gov
    TSCV (Half-strength) DRUG Phase PHASE2 Trivalent Salmonella Conjugate Vaccine (TSCV) ClinicalTrials.gov
    TSCV (Full-strength) DRUG Phase PHASE2 Trivalent Salmonella Conjugate Vaccine (TSCV) ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval: Not available
    • Executive Changes: Not available

    Structured Data:

    • Company Name: WW INTERNATIONAL, INC.
    • Ticker Symbol: WW